{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:20:41Z","timestamp":1791652841511,"version":"4.3.4"},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T00:00:00Z","timestamp":1662768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ad.2022.03.022","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T11:41:10Z","timestamp":1663155670000},"page":"183-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Excelente respuesta cl\u00ednica a largo plazo con rivaroxab\u00e1n en vasculopat\u00eda livedoide. Un estudio retrospectivo"],"prefix":"10.1016","volume":"114","author":[{"given":"D.","family":"Morgado-Carrasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ibaceta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Iranzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Bosch-Amate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Mascar\u00f3-Galy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2022.03.022_bib0050","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1016\/S2352-3026(15)00251-3","article-title":"Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): A multicentre, single-arm, open-label, phase 2a, proof-of-concept trial","volume":"3","author":"Weishaupt","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ad.2022.03.022_bib0055","doi-asserted-by":"crossref","first-page":"e15051","DOI":"10.1111\/dth.15051","article-title":"Rivaroxaban for treatment of livedoid vasculopathy: A systematic review","volume":"34","author":"Gao","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2022.03.022_bib0060","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1111\/jdv.16129","article-title":"Livedoid vasculopathy in Koreans: Clinical features and response to rivaroxaban treatment","volume":"34","author":"Lee","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2022.03.022_bib0065","doi-asserted-by":"crossref","first-page":"e14810","DOI":"10.1111\/dth.14810","article-title":"Livedoid vasculopathy in 75 Brazilian patients in a single-center institution: Clinical, histopathological and therapy evaluation","volume":"34","author":"Criado","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2022.03.022_bib0070","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ad.2017.07.015","article-title":"Treatment of livedoid vasculopathy with rivaroxaban: A potential use of new oral anticoagulants for dermatologists","volume":"109","author":"Jim\u00e9nez-Gallo","year":"2018","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"10.1016\/j.ad.2022.03.022_bib0075","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/bjd.12100","article-title":"Rivaroxaban prevents painful cutaneous infarctions in livedoid vasculopathy","volume":"168","author":"Kerk","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2022.03.022_bib0080","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/ced.12829","article-title":"Case series of recalcitrant livedoid vasculopathy treated with rivaroxaban","volume":"41","author":"Lee","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ad.2022.03.022_bib0085","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1111\/jdv.14404","article-title":"Prevention of livedoid vasculopathy recurrence by prolonged administration of rivaroxaban","volume":"31","author":"Drerup","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2022.03.022_bib0090","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2147\/JPR.S133462","article-title":"Treatment application of rivaroxaban in Chinese patients with livedoid vasculopathy","volume":"10","author":"Chen","year":"2017","journal-title":"J Pain Res"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731022007876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731022007876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:14:59Z","timestamp":1757553299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731022007876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0001731022007876"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2022.03.022","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Excelente respuesta cl\u00ednica a largo plazo con rivaroxab\u00e1n en vasculopat\u00eda livedoide. Un estudio retrospectivo","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2022.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of AEDV.","name":"copyright","label":"Copyright"}]}}